Antipodes
Nick Cameron is a Portfolio Manager at Antipodes with a background in global healthcare stocks research. Prior to their current role, Nick was an Investment Analyst and Portfolio Manager at Watermark Funds Management. Nick has also worked as a Corporate Strategy Investment Analyst at Biomed Advisors, a Business Development and M&A Analyst at GenesisCare, and as a Research Analyst in the healthcare and biotechnology sectors at Deutsche Bank and Credit Suisse. Nick has a Doctor of Philosophy in Molecular Biology, Neuroscience, and Biomedical, as well as Bachelor's degrees in Biotechnology and Science.
This person is not in any teams
Antipodes
1 followers
Antipodes is a global asset manager offering a pragmatic value approach across long only and long-short strategies. We aspire to grow client wealth over the long-term by generating absolute returns in excess of the benchmark, at below market levels of risk. We seek to take advantage of the market’s tendency for irrational extrapolation, identify investments that offer a high margin of safety and build portfolios with a capital preservation focus. Antipodes is majority owned by its seasoned investment team with over 150 years of combined global experience. Our performance culture is underpinned by sensible incentives, a focused offering and the outsourcing of non-investment functions to minority partner Pinnacle Investment Management Limited. For more information or to subscribe for updates please contact invest@antipodespartners.com